The global healthcare landscape is witnessing a significant shift toward minimally invasive treatments, particularly in the management of vascular diseases. At the forefront of this transformation is the peripheral vascular devices market, which continues to expand as demand rises for safer, faster, and more effective treatment options.
The global peripheral vascular devices market is valued at USD 9.55 billion in 2025, reaching USD 10.02 billion in 2026, and is projected to grow at a CAGR of 5.7%, reaching approximately USD 13.22 billion by 2031. This growth is largely driven by the increasing prevalence of peripheral artery disease (PAD) and other vascular conditions, along with technological advancements in endovascular therapies.
As healthcare systems prioritize patient-centric care, the adoption of less-invasive procedures with shorter recovery times is accelerating the demand for peripheral vascular devices worldwide.
Rising Burden of Vascular Diseases Driving Demand
One of the most significant factors fueling market growth is the rising incidence of vascular diseases, particularly PAD, chronic kidney disease (CKD), and end-stage renal disease (ESRD).
These conditions are increasingly common due to:
- Aging global populations
- Rising rates of diabetes and obesity
- Sedentary lifestyles
- Smoking and hypertension
As these risk factors continue to grow, so does the need for effective diagnostic and therapeutic solutions. Peripheral vascular devices play a critical role in managing these conditions by enabling early intervention, improved blood flow, and prevention of severe complications such as limb loss.
Shift Toward Minimally Invasive Endovascular Procedures
A major trend shaping the market is the growing preference for minimally invasive endovascular procedures over traditional open surgeries.
Patients and healthcare providers are increasingly opting for these procedures due to:
- Reduced hospital stays
- Faster recovery times
- Lower risk of complications
- Improved patient comfort
Technologies such as angioplasty balloons, stents, atherectomy devices, and advanced imaging systems have significantly enhanced the effectiveness of these procedures, making them widely accessible across healthcare settings.
Key Market Insights and Segmentation
The peripheral vascular devices market includes a wide range of products, each contributing to improved diagnosis and treatment outcomes.
Atherectomy Devices Leading the Market
Among device categories, atherectomy devices account for a significant share (65.5%), reflecting their importance in removing plaque buildup and restoring blood flow in affected vessels.
Guidewires and Catheters as Essential Tools
Guidewires (44%) and guiding catheters (48.7%) hold substantial market shares, as they are fundamental components in most endovascular procedures.
Their role in navigating blood vessels and delivering therapeutic devices makes them indispensable in vascular interventions.
Embolic Protection and Filters
Embolic protection devices (63.7%) and retrievable filters (71.4%) are widely used to prevent complications during procedures by capturing debris and maintaining safe blood flow.
Balloon Technologies and Stents
Traditional angioplasty balloons continue to dominate, while drug-eluting stents and advanced stent grafts are gaining traction due to their ability to improve long-term outcomes and reduce restenosis.
Market Driver: Increasing Prevalence of PAD and Chronic Conditions
The primary driver of the peripheral vascular devices market is the growing prevalence of PAD and related chronic conditions.
As vascular diseases progress, patients often require interventional procedures to restore blood circulation and prevent complications. Peripheral vascular devices enable these interventions with high precision and safety.
Advancements such as drug-coated balloons, self-expanding stents, and image-guided systems have further improved procedural success rates, encouraging wider adoption among clinicians.
In addition, increasing awareness among patients and healthcare providers about early diagnosis and treatment is contributing to market growth.
Emerging Opportunity: Growth of Ambulatory Surgical Centers (ASCs)
One of the most promising opportunities in the market is the expansion of ambulatory surgical centers (ASCs).
ASCs are becoming increasingly popular for vascular procedures due to their:
- Cost-effectiveness
- Shorter procedure times
- Same-day discharge capabilities
- Reduced burden on hospitals
Advancements in device design—such as smaller, more user-friendly tools—have made it possible to perform complex vascular procedures in outpatient settings.
Favorable reimbursement policies and growing patient preference for convenient care are further accelerating the adoption of ASCs.
Technological Advancements Driving Innovation
Innovation is a key factor shaping the future of the peripheral vascular devices market.
Drug-Eluting Technologies
Drug-eluting stents and balloons are improving treatment outcomes by reducing restenosis and enhancing vessel healing.
Advanced Imaging Systems
Imaging technologies are enabling more accurate diagnosis and precise navigation during procedures, improving overall success rates.
Next-Generation Device Design
Modern devices are being designed with enhanced:
- Flexibility
- Durability
- Ease of use
These improvements are expanding the range of patients eligible for treatment and improving procedural efficiency.
Product Insights: Angioplasty Stents and Catheters
Drug-Eluting Stents Gaining Momentum
Among angioplasty stents, drug-eluting stents are expected to grow at the fastest rate, driven by their superior performance in maintaining vessel patency.
Their ability to release medication directly into the artery helps prevent re-narrowing, making them a preferred choice for many clinicians.
Angiography Catheters Leading Demand
Angiography catheters account for the largest share within the catheter segment, as they are essential for imaging and guiding interventions.
Improvements in catheter design—such as better flexibility and radiopacity—have enhanced procedural accuracy and efficiency.
Regional Outlook: North America Leading the Market
North America dominates the global peripheral vascular devices market, supported by:
- High prevalence of vascular diseases
- Advanced healthcare infrastructure
- Early adoption of innovative technologies
- Strong presence of leading manufacturers
Favorable reimbursement policies and increasing use of outpatient procedures further strengthen the region’s leadership.
Competitive Landscape and Key Players
The peripheral vascular devices market is highly competitive, with several global and regional players driving innovation.
Key companies include:
- Boston Scientific Corporation
- Medtronic Plc
- Abbott
- Becton, Dickinson and Company
- Terumo Corporation
- B. Braun Melsungen AG
- Merit Medical Systems
- Penumbra, Inc.
- Koninklijke Philips
- Stryker
- Cook Medical
Emerging players such as Meril Life Sciences, ALVIMEDICA, CARDIONOVUM, SMT, and Medinol are also gaining traction by focusing on specialized technologies and cost-effective solutions.
The Future of Peripheral Vascular Devices
The future of the peripheral vascular devices market lies in continued innovation, improved patient outcomes, and expanded access to minimally invasive care.
As the global burden of vascular diseases continues to rise, the demand for advanced, efficient, and patient-friendly treatment options will grow.
With ongoing advancements in device technology, increasing adoption of outpatient procedures, and expanding healthcare infrastructure in emerging markets, the industry is well-positioned for sustained growth.
Ultimately, peripheral vascular devices will remain a critical component of modern cardiovascular care, enabling clinicians to deliver safer, faster, and more effective treatments for patients worldwide.